Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Kidney Failure, Chronic × belantamab mafodotin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Genitourinary 1

Conditions

Multiple Myeloma 9 Renal Insufficiency 1 Recurrence 1 Neoplasms, Plasma Cell 1 Kidney Failure, Chronic 1

Interventions

Kidney Transplantation 2 peginesatide 1 hematide 1 carfilzomib 1 belantamab mafodotin 1 Sitagliptin Phosphate 1 Duration of Therapy 1 Cyclosporine 1 Cyclophosphamide 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04398745 2025-05-23

DREAMM12

GlaxoSmithKline

Phase 1 Active not recruiting

GenitourinaryPlasma cell

Kidney Failure, Chronic, Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡